<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04253392</url>
  </required_header>
  <id_info>
    <org_study_id>TRX_2018_01</org_study_id>
    <nct_id>NCT04253392</nct_id>
  </id_info>
  <brief_title>RETHINK REFLUX Registry</brief_title>
  <official_title>Research to Further Inform Thinking About the Role of LINX for Reflux Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon Endo-Surgery</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon Endo-Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single&#xD;
      arm, long-term safety surveillance registry of subjects implanted with the LINX device. The&#xD;
      primary objective of the study is to confirm the long-term safety profile of the LINX device&#xD;
      and procedure (implant/explant) up to 10 years post-implant.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The RETHINK REFLUX Registry or Research to further inform thinking about the role of LINX for&#xD;
      Reflux Disease is sponsored by Ethicon Endo-Surgery, Inc. This is a post-market prospective,&#xD;
      multi-center, observational, single arm, long-term safety surveillance registry of subjects&#xD;
      implanted with the LINX device. Up to 500 subjects will be enrolled and implanted at up to 50&#xD;
      centers in both the US and selected countries outside the US with regulatory approval for the&#xD;
      LINX Reflux Management System. The study will collect data from patients 10 years post&#xD;
      implant. The primary objective of the study is to confirm the long-term safety profile of the&#xD;
      LINX device and procedure (implant/explant). Secondary objectives include Effectiveness,&#xD;
      Health Economics and Health Utilization.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 8, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2032</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2032</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Safety - Adverse Events</measure>
    <time_frame>10 years</time_frame>
    <description>Adverse events related to the LINX device and/or procedure (implant/explant) limited to:&#xD;
All related serious adverse events&#xD;
All related adverse events of dysphagia and or odynophagia requiring treatment (only)&#xD;
LINX migration&#xD;
LINX erosion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety - Explant/Removal</measure>
    <time_frame>10 years</time_frame>
    <description>LINX explant/removal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety - Hiatal Hernia Reoccurrence</measure>
    <time_frame>10 years</time_frame>
    <description>Hiatal hernia requiring repair (occurring after the LINX implant)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effectiveness</measure>
    <time_frame>10 years</time_frame>
    <description>Follow-up questionnaires Gastroesophageal Reflux Disease Esophageal Health Related Quality of Life Questionnaire (GERD-HRQL), Foregut Symptoms Questionnaire (FSQ) and GERD Medication Survey] will be collected and compared to baseline with evaluation to include:&#xD;
Percentage of subjects reporting &gt;or=50% reduction in GERD-HRQL scores&#xD;
Percentage of subjects reporting the following on the FSQ:&#xD;
Elimination of moderate or severe regurgitation&#xD;
Reduction in extra-esophageal symptoms&#xD;
Maintain the ability to belch&#xD;
Maintain the ability to vomit&#xD;
Percentage of subjects reporting &gt; or = 50% reduction in average daily proton pump inhibitor (PPI) use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economics - Work Productivity and Activity Impairment</measure>
    <time_frame>10 years</time_frame>
    <description>Measure of the impact of GERD on a subject's ability to work will be collected through the responses on the Work Productivity and Activity Impairment (WPAI) questionnaire. Percentages of impairment at baseline will be compared to scores collected annually. Four types of scores will be analyzed:&#xD;
Absenteeism (work time missed)&#xD;
Presenteeism (impairment of work/ reduced on-the-job effectiveness)&#xD;
Work productivity loss (overall work impairment/ absenteeism plus presenteeism)&#xD;
Activity impairment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economics - GERD Treatment Decision-Making Process (Subject's Perspective)</measure>
    <time_frame>Baseline</time_frame>
    <description>To better understand a subject's process for making GERD related healthcare decisions and his/her care pathways, the LINX Interest Survey will be collected once at baseline, prior the implant procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economics - Healthcare Utilization</measure>
    <time_frame>10 years</time_frame>
    <description>Analysis of healthcare economics in subjects who seek treatment for worsening of GERD symptoms and device/procedural complications over 10 years. A Healthcare Encounter Survey will be completed by subjects.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Gastroesophageal Reflux</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LINX Reflux Management System</intervention_name>
    <description>The LINX Reflux Management System consists of a series of titanium beads each with a magnetic core connected with independent titanium wires to form an annular shape when implanted. The attractive force of the magnetic beads is designed to provide additional strength to keep a weak lower esophageal sphincter (LES) closed. During swallowing, the magnetic beads slide away from each other on the independent titanium wire &quot;links&quot; to allow esophageal distention as the bolus passes by.</description>
    <other_name>LINX</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients successfully implanted (treated) with the LINX Reflux Management System for&#xD;
        the treatment of GERD (Implant success defined as leaving the surgical suite with a device&#xD;
        in situ)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is &gt;or=21 years old&#xD;
&#xD;
          2. Subject with prospective plans for a LINX procedure&#xD;
&#xD;
          3. Subject provides written informed consent&#xD;
&#xD;
          4. Subject must be willing and able to complete questionnaires/ surveys electronically&#xD;
             (ePROs)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject who was previously implanted with LINX device&#xD;
&#xD;
          2. Any reason which the Principal Investigator believes may cause the subject to be&#xD;
             non-compliant with or unable to meet the protocol requirements (i.e. medical illness&#xD;
             and/or limited life expectancy of less than 10 years)&#xD;
&#xD;
        Note: Physicians should refer to the LINX Reflux Management System IFU for a complete list&#xD;
        of contraindications, warnings, and precautions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William J. Petraiuolo, MD, FACS</last_name>
    <role>Study Director</role>
    <affiliation>Ethicon Endo-Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leslee Sprague, PhD</last_name>
    <phone>5133371255</phone>
    <email>LSpragu2@ITS.JNJ.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of South Alabama</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36617</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. William O. Richards</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NW Allied Bariatric and Foregut Surgery</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Patrick M. Chiasson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keck Hospital of USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Caitlin C. Houghton</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Esophageal and Reflux Surgery</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Reginald CW Bell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OSF Medical Group</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Benjamin F. Gerber</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Elizabeth Healthcare Edgewood</name>
      <address>
        <city>Edgewood</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Valerie A. Williams</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Carolina University / Vidant Medical Center</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Carlos J. Anciano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Leena Khaitan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Kyle A. Perry</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gen Surg Assoc / Fairfield Medical Center</name>
      <address>
        <city>Lancaster</city>
        <state>Ohio</state>
        <zip>43130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Jeffrey K. Yenchar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Oregon Clinic</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Christy M. Dunst</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minimal Access Surgery/Prisma Health - Upstate</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Shanu N. Kothari</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Adv Surg Assoc / Self Regional Healthcare</name>
      <address>
        <city>Greenwood</city>
        <state>South Carolina</state>
        <zip>29646</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Jeffrey B. Thomas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lexington Surgery</name>
      <address>
        <city>West Columbia</city>
        <state>South Carolina</state>
        <zip>29169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Marc C. Antonetti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Panhandle Weight Loss Center</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Darren L. Peterson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas - Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. F. Paul Buckley III</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Health</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Steven G. Leeds</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Min P. Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Richmond Surg / Henrico Doctors' Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Clifford L. Smith</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dr. Brian E. Louie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fox Valley Surgical Associates</name>
      <address>
        <city>Appleton</city>
        <state>Wisconsin</state>
        <zip>54911</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dr. Peter G. Janu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedUni Wien / Universitatsklinik fur Chirurgie</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Prof. Dr. med. Sebastian F. Schoppmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marien Hospital Herne</name>
      <address>
        <city>Herne</city>
        <zip>44625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Dr. med. Dirk Bausch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stiftungklinikum PROSELIS, St. Elisabeth-Hospital</name>
      <address>
        <city>Herten</city>
        <zip>45699</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Dr. med. Dr. Matthais Heuer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univ of Milano / IRCCS Policlinico San Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Prof. Luigi Bonavina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Prof. Dr. Asim Shabbir</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Epsom Hospital</name>
      <address>
        <city>Epsom</city>
        <zip>KT18 7EG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dhiren Nehra, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guy's and St. Thomas' Hospitals</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>James A. Gossage, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spire Tunbridge Wells Hospital</name>
      <address>
        <city>Tunbridge Wells</city>
        <zip>TN3 0RD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicholas H. Boyle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Singapore</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 31, 2020</study_first_submitted>
  <study_first_submitted_qc>January 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastroesophageal Reflux Disease</keyword>
  <keyword>GERD</keyword>
  <keyword>Reflux</keyword>
  <keyword>Regurgitation</keyword>
  <keyword>Esophageal Disease</keyword>
  <keyword>Lower Esophageal Sphincter</keyword>
  <keyword>LES</keyword>
  <keyword>Magnetic Sphincter Augmentation</keyword>
  <keyword>MSA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.</ipd_description>
    <ipd_url>http://yoda.yale.edu.</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

